Dr. Varun Khurana obtained his Bachelors in Pharmacy from Guru Gobind Singh Indraprastha University, Delhi India. Dr. Khurana graduated with a Ph.D. in Pharmaceutical Sciences and Chemistry from reputed University of Missouri Kansas City, Kansas City, MO, USA. Currently, he is working as a Formulations Scientist at Nevakar LLC, USA, a specialty pharmaceutical company that develops and commercializes innovative supportive care products. Dr. Khurana's research experience encompasses both industry and academia. Dr. Khurana worked on National Institutes of Health (NIH) funded research projects. Dr. Khurana's research was focused on understanding the role of drug transporters (influx as well as efflux) in disposition of various anti-cancer drugs. He not only studied the alteration of drug pharmacokinetics via drug transporters in liver but also how the modulation affects brain as well plasma pharmacokinetics of anti-cancer drugs. Furthermore, his research work was focused on ocular drug delivery through nanoparticles. His research has been published in several peer-reviewed journals and books in the field of pharmaceutical sciences. Dr. Khurana's current research at Nevakar is focused on developing innovative products in injectable and ophthalmic space.
Novel Drug Delivery Systems; Solubility and Bioavailability Enhancement; Targeted Drug Delivery; Cancer Therapy; Targeted Delivery; Gene Therapy; Nanotechnology; Novel Drug Delivery Systems; Formulation Development (Oral solids; Liquid and Parenterals/Injectables); Controlled or Modified Release; Inhalations and Nanocrystals.